Wolf Research upgraded Walt Disney (DIS) shares to ‘Outperform’ from ‘Peer Perform’ on Monday, citing durable strengths in ...

Shares of Intellia Therapeutics (NASDAQ:NTLA) were up over 10% on Monday, after Wolfe Research upgraded the company to ...

Wolfe Research upgraded Disney (DIS) to Outperform from Peer Perform with a $112 price target The firm says the Disney “castle” is “intact” ...

Wolfe Research's Peter Supino downgraded the stock’s Tokyo-listed shares, which fell 10% on Monday amid Trump's tariffs.

Investing.com -- Wolfe Research upgraded U.S. Bancorp (BVMF:USBC34) to "Outperform," citing a attractive valuation and expected improvements in operating performance. USB has been the worst ...

Wolfe Research initiated coverage of Kestra Medical (KMTS) with an Outperform rating and $29 price target Kestra, which launched its ASSURE ...

Wolfe Research upgraded Equinix (NASDAQ:EQIX) to Outperform as its strong balance sheet would offer support in a downturn and the data center REIT is "well-suited for retail inference." ...

Wolfe Research restated their peer perform rating on shares of AZEK (NYSE:AZEK – Free Report) in a research report sent to investors on Wednesday, Marketbeat reports. AZEK has been the topic of ...

Wolfe Research adjusted its price targets and earnings forecasts for Alcoa (NYSE:AA) Corp and Century Aluminum (NASDAQ:CENX) Company, reflecting changes in the alumina market and the impact of tariffs ...

Wolfe Research highlighted key technicals levels for three popular exchange-traded funds: the SPDR S&P 500 ETF Trust (NYSEARCA:SPY), the Invesco QQQ Trust ETF (NASDAQ:QQQ), and the iShares Russell ...

Colossal Biosciences made global headlines when they announced that they had successfully brought the dire wolf back from ...

Management will host investor meetings throughout the day. For further information, please contact your Wolfe Research representative or email [email protected]. About Paymentus Paymentus is a ...